1[1]Lennihan L,Mayer SA,Fink ME,et al.Effect of hypervolemic therapy on cerebral blood flow after subarachnoid haemorrhage:a randomized controlled trial.Stroke,2000,31(2):383-391
2[2]Firlik AD,Kaufmann AM,Jungreis CA,Yonas H.Effect of transluminal angioplasty on cerebral blood flow in the management of symptomatic vasospasm following aneurysmal subarachnoid hemorrhage.J Neurosurg,1997,86(5):830-839
3[3]Fujiwara N,Honjo Y,Ohkawa M,et al.Effectiveness of percutaneous transluminal angioplasty and intra-arterial papaverine infusion for symptomatic vasospasm after subarachnoid hemorrhage.Nippon Igaku Hoshasen Gakkai Zasshi,1997,57(7):412-417
4[4]Minato H,Hashizume M,Masuda Y,et al.Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6,11 -dihydrodibenz[ b,e ] oxepin-11-yl) -4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerbral arteries of rabbit and dog.Arzneimittelforschung,1997,47 (4):339-346
5[5]Roux S,Breu V,Giller T,et al.Ro 61-1790,a new hydrosoluble endothelin antagonist:general pharmacology and effects on experimental cerebral vasospasm.J Pharmacol Exp Ther,1997,283(3):1110-1118
6[6]Zimmermann M.Endothelin in cerebral vaspasm.Clinical and experimental results.J Neurosurg Sci,1997,41(2):139-151
7[7]Kwan AL,Bavbek M,Jeng AY,et al.Prevention and reversal of cerebral vasospasm by an endothelin-converting enzyme inhibitor,CGS26303,in an experimental model of subarachnoid hemorrhage,J Neurosurg,1997,87(2):281-286
8[8]Mima T,Mostafa MG,Mori K.Therapeutic dose and timing of administration of RNA synthesis inhibitors for preventing cerbral vasospasm after subarachnoid hemorrhage.Acta Neurochir[ Suppl ] (Wien),1997,70(1):65-67
9[9]Yamamoto S,Nishizawa S,Yokoyama T,et al.Subarachnoid hemorrhage impairs cerbral blood flow response to nitric oxide but not to cyclic GMP in large cerbral arteries.Brain Res,1997,757(1):1-9
10[10]Khajavi K,Ayzman I,Shearer D,et al.Prevention of chronic cerebral vasospasm in dogs with milrinone.Neurosurgery,1997,40(2):354-362
